Key result
In chronically diabetic mice, mEPSP amplitude following tetanic stimulation was reduced in STZ mice (3.71 ± 0.3 vs 4.95 ± 0.4 mV, P=0.03) but not db/db mice compared to controls.
Absolute Event Rate: 3.71% vs 4.95%
p-value: p=0.03
While parasympathetic neurotransmission at the major pelvic ganglion remains intact in chronically diabetic mice, obese type 2 diabetic animals exhibit altered presynaptic regulation of neurotransmitter release.
Differential effects on ganglionic transmission in diabetic mouse models; leaves open translation to human autonomic neuropathy.
Bladder and erectile dysfunction are common urologic complications of diabetes and are associated with reduced parasympathetic autonomic control. To determine whether disruption of ganglionic neurotransmission contributes to the loss of function, we investigated synaptic transmission at parasympathetic, major pelvic ganglion (MPG) neurons in control and chronically (20 wk) diabetic mice. In contrast to what has been reported for sympathetic neurons, diabetes did not cause an interruption of synaptic transmission at parasympathetic MPG neurons from streptozotocin-treated C57BL/6J (STZ) or db/db mice. Cholinergically mediated excitatory postsynaptic potentials (EPSPs) were suprathreshold during 5-s trains of 5-, 10-, and 20-Hz stimuli. Asynchronous neurotransmitter release, observed as miniature EPSPs (mEPSPs) during and after stimulation, permitted quantitative assessment of postganglionic, cholinergic receptor sensitivity. mEPSP amplitude following tetanic stimulation (recorded at -60 mV) was reduced in STZ (4.95 ± 0.4 vs. 3.71 ± 0.3 mV, P = 0.03), but not db/db mice. The number of posttetanic mEPSPs was significantly greater in db/db mice at all frequencies tested. Assessment of basic electrophysiological properties revealed that parasympathetic MPG neurons from db/db mice had less negative membrane potentials, lower input resistances, and shorter afterhyperpolarizations relative to their control. MPG neurons from STZ had longer afterhyperpolarizations but were otherwise similar to controls. Membrane excitability, measured by the membrane responsiveness to long-duration (1 s), suprathreshold depolarizing pulses, was unchanged in either model. The present study indicates that, while parasympathetic neurotransmission at the MPG is intact in chronically diabetic mice, obese, type 2 diabetic animals exhibit an altered presynaptic regulation of neurotransmitter release.
No takes yet. Share an insight, caveat, or question.
Tompkins et al. (2012) studied Diabetes. Diabetes (STZ or db/db models) vs. Control mice was evaluated on mEPSP amplitude following tetanic stimulation (recorded at -60 mV) (p=0.03). In chronically diabetic mice, mEPSP amplitude following tetanic stimulation was reduced in STZ mice (3.71 ± 0.3 vs 4.95 ± 0.4 mV, P=0.03) but not db/db mice compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: